Telmisartan 80mg Non-responder Trial

NCT01222520 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

174

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Telmisartan and amlodipine
DRUG: Telmisartan

Sponsor

Boehringer Ingelheim